Chargement en cours...

Adjuvant Endocrine Therapy in Premenopausal Patients

Endocrine adjuvant therapy is the best-described molecular targeted treatment and should therefore be used for all patients with endocrine-responsive breast cancer. Ta-moxifen for 5 years is standard of care and has proven efficacy in premenopausal patients. The combination of tamoxifen with ovarian...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Gnant, Michael
Format: Artigo
Langue:Inglês
Publié: S. Karger GmbH 2008
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931102/
https://ncbi.nlm.nih.gov/pubmed/20824025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000156985
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!